UroGen Pharma
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $37,837 | $27,482 | $24,215 | $20,254 |
Gross Profit | 34,548 | 24,204 | 20,665 | 17,924 |
EBITDA | -22,188 | -25,768 | -48,818 | -38,886 |
EBIT | -22,867 | -26,407 | -49,414 | -39,383 |
Net Income | -26,364 | -33,347 | -49,940 | -43,843 |
Net Change In Cash | 37,837 | 27,482 | 24,215 | 20,254 |
Free Cash Flow | -38,342 | -42,357 | -39,966 | -42,068 |
Cash | 110,745 | 90,039 | 92,904 | 104,033 |
Basic Shares | 49,230 | 48,057 | 47,739 | 47,422 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $109,788 | $90,398 | $82,713 | $64,357 |
Gross Profit | 97,341 | 81,517 | 73,352 | 56,703 |
EBITDA | -135,660 | -95,353 | -60,352 | -76,214 |
EBIT | -138,071 | -95,682 | -62,057 | -78,031 |
Net Income | -153,494 | -126,874 | -102,244 | -109,783 |
Net Change In Cash | 109,788 | 90,398 | 82,713 | 64,357 |
Cost of Revenue | 10,635 | |||
Free Cash Flow | -162,733 | -97,061 | -76,570 | -87,813 |
Cash | 110,745 | 171,987 | 95,002 | 55,408 |
Basic Shares | 48,116 | 42,876 | 28,834 | 22,806 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.53 |
2025-09-30 | -$0.69 |
2025-06-30 | -$1.05 |
